Cargando…
Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanoma
We report on a 36-year-old woman treated with the anti PD-1 antibody Pembrolizumab for metastatic cutaneous melanoma in the first line setting. She achieved a complete response and then relapsed with metastases to the vitreous cavity with an associated angiographically determined retinal vasculitis....
Autores principales: | Manusow, Joshua S, Khoja, Leila, Pesin, Nataly, Joshua, Anthony M, Mandelcorn, Efrem D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266968/ https://www.ncbi.nlm.nih.gov/pubmed/25516805 http://dx.doi.org/10.1186/s40425-014-0041-1 |
Ejemplares similares
-
Combination intravitreous melphalan and bevacizumb for cutaneous metastatic melanoma to the vitreous and retina
por: Francis, Jasmine H., et al.
Publicado: (2022) -
Anatomical and functional outcomes of short-term DensironXTRA heavy silicone oil for rhegmatogenous retinal detachments: a comparative case series
por: Felfeli, Tina, et al.
Publicado: (2023) -
The full blood count as a biomarker of outcome and toxicity in ipilimumab‐treated cutaneous metastatic melanoma
por: Khoja, Leila, et al.
Publicado: (2016) -
Combined Pars Plana Vitrectomy and Segmental Scleral Buckle for Rhegmatogenous Retinal Detachment with Inferior Retinal Breaks
por: Arjmand, Parnian, et al.
Publicado: (2021) -
Significance of metastatic topography for the immunotherapy of cutaneous and ocular melanomas
por: Săftescu, Sorin, et al.
Publicado: (2020)